# A/H1N1 Immunogenicity and Safety in Adults

> **NCT00959465** · PHASE1,PHASE2 · COMPLETED · sponsor: **Alachua Government Services, Inc.** · enrollment: 408 (actual)

## Conditions studied

- Influenza
- Pandemic Influenza

## Interventions

- **BIOLOGICAL:** H1N1 pandemic influenza vaccine (whole virion, Vero Cell-derived, inactivated)

## Key facts

- **NCT ID:** NCT00959465
- **Lead sponsor:** Alachua Government Services, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2009-11
- **Final completion:** 2010-04
- **Target enrollment:** 408 (ACTUAL)
- **Last updated:** 2015-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00959465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00959465, "A/H1N1 Immunogenicity and Safety in Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00959465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*